We can be with you on your projects.
Crizotinib
Crizotinib Contact Us Mechanism of action: Inhibitor of c-MET and ALK receptor tyrosine kinases Indications: Non-small cell lung cancer that has spread to other parts of the
Dasatinib H2O
Dasatinib H2O Contact Us Mechanism of action: Src family kinase inhibitor (c-Abl and Bcr-Abl). Indications: CML (Chronic Phase), CML (Advanced), ALL (Philadelphia chromosome-positive). Chemical
Dimethyl Fumarate
Dimethyl Fumarate Contact Us Mechanism of action: Anti-inflammatory and cytoprotective properties via activation of the Nrf2 pathway Therapeutic Indications: Multiple Sclerosis (MS). Chemical Name: Trans-1,2-Ethylenedicarboxylic
Empagliflozin
Empagliflozin Contact Us Mechanism of action: Sodium glucose co-transporter-2 inhibitor (SGLT-2). Therapeutic Indications: Type 2 diabetes Chemical Name: (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol. Details
Enzalutamide
Enzalutamide Contact Us Mechanism of action: Antagonist of the androgen receptor (the biological target of androgens like testosterone and dihydrotestosterone ) Indications: metastatic castration-resistant prostate cancer (mCRPC)
Erlotinib HCl
Erlotinib HCl Contact US Mechanism of action: EGFR tyrosine kinase inhibitor. Indications: Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer. Chemical Name: N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride Details
Fingolimod hydrochloride
Fingolimod hydrochloride Mechanism of action: Sphingosine-1-phosphote receptor modulator Indication: Relopsing forms of multiple sclerosis (RMS) Chemical Name: 2-amino-2-[2-(4-octylphenyl) ethyl] propane-1,3-diol hydrochloride Details
Flibanserin
Flibanserin Contact Us Mechanism of action: 5-HT1A agonist, 5-HT2A antagonist and D4 antagonist. Therapeutic Indications: Hypoactive sexual desire disorder among women. Chemical Name:
Imatinib Mesylate
Imatinib Mesylate Contact Us Mechanism of action: Tyrosine kinase inhibitor (specific for abnormal BCR-ABL tyrosine kinase produced by Philadelphia chromosome in CML/ALL) Indications: Acute lymphoblastic leukemia, Chronic
Lenalidomide Hemihydrate
Lenalidomide Hemihydrate Contact US Mechanism of action: Inhibits secretion of proinflammatory cytokines; enhances cell-mediated immunity by stimulating proliferation of anti-CD3 stimulated T cells. Therapeutic indications: Multiple
Linagliptin
Linagliptin Mechanism Of action: Dipeptidyl peptidose-4 inhlbitor Indication: Diobeties mellitus type 2 . Chemical Name: 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl) methyl] purine
Nilotinib
Nilotinib HCl,H2O Contact Us Mechanism of action: Multikinase inhibitor (BCR-ABL, c-Kit, PDGF-R). Indications: Chronic Myeloid Leukemia (CML) . Chemical Name: 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl] amino]-benzamide, hydrochloride, hydrate.
Ozanimod
Ozanimod Mechanism of action: Sphingosine-1-phosphote (SIP) receptor agonist Indication: Relopsing Multiple sclerosis (RMS) and ulcerative colitis (UC) Chemical Name: 5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile Details
Palbociclib
Palbociclib Contact Us Mechanism of action: Cyclin-dependent kinase inhibitor (CDK4 & CDK6). Indications: Breast Cancer. . . Chemical Name: 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one. Details
Pazopanib HCl
Pazopanib HCl Contact Us Mechanism of action: Multi tyrosine kinase inhibitor; (VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-alpha & beta, FGFR-1 & -3, cKIT, Lck, c-Fms). Indications: Advanced Renal Cell
Rivaroxaban
Rivaroxaban Contact Us Mechanism of action: Selective and reversible factor Xa inhibitor. Therapeutic Indications: Stroke Prophylaxis with Atrial Fibrillation, Postoperative Prophylaxis and treatment of Deep vein thrombosis
Ruxolitinib
Ruxolitinib Contact Us Mechanism of action: Janus kinase (JAK1 & JAK2) inhibitor Indications: Intermediate or high-risk myelofibrosis Chemical Name: (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl) pyrazol-1-yl]propane nitrile
Siponimod fumaric acid
Siponimod fumaric acid Mechanism of action: Selective sphingosine-1-phosphate receptor modulotor Indication: Multiple sclerosis (MS)
Sorafenib Tosylate
Sorafenib Tosylate Contact US Mechanism of action: Multikinase inhibitor (VEGF-R, PDGF-R and Raf family kinases). Indications: Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Cancer. ج ک
Sunitinib Malate
Sunitinib Malate Contact Us Mechanism of action: Multikinase inhibitor (VEGF-R1, VEGF-R2, VEGF-R3, PDGF-Rα, PDGF-Rβ, KIT, FLT3, CSF-1R, and RET). Indications: Gastrointestinal Stromal Tumor (GIST), Advanced Renal Cell
Teriflunomide
Teriflunomide Contact Us Mechanism of action: Pyrimidine Synthesis Inhibitor Therapeutic Indications: Multiple Sclerosis (MS). Chemical Name: (Z)-2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide. Details Molecular Weight: 270.21
